Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levonorgestrel - AbbVie

Drug Profile

Levonorgestrel - AbbVie

Alternative Names: AVIBELA; Levonorgestrel intrauterine - AbbVie; Levosert; LILETTA; LNG20

Latest Information Update: 12 Jul 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mithra Pharmaceuticals
  • Developer AbbVie; Medicines360; Population Services International
  • Class Hormonal contraceptives; Hormonal replacements; Norpregnanes; Progesterone congeners; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Menorrhagia; Pregnancy

Most Recent Events

  • 10 Jul 2023 Registered for Menorrhagia in USA (Intrauterine)
  • 10 Jul 2023 The US FDA approves sNDA for extension of use of levonorgestrel for up to five years for Menorrhagia in USA (Intrauterine)
  • 14 Nov 2022 The US FDA approves sNDA for extension of use of levonorgestrel intrauterine for up to eight years Contraception in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top